BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 10458216)

  • 1. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study.
    Rose PG; Adler LP; Rodriguez M; Faulhaber PF; Abdul-Karim FW; Miraldi F
    J Clin Oncol; 1999 Jan; 17(1):41-5. PubMed ID: 10458216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings.
    Yeh LS; Hung YC; Shen YY; Kao CH; Lin CC; Lee CC
    Oncol Rep; 2002; 9(6):1289-92. PubMed ID: 12375036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings.
    Lin WC; Hung YC; Yeh LS; Kao CH; Yen RF; Shen YY
    Gynecol Oncol; 2003 Apr; 89(1):73-6. PubMed ID: 12694656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
    Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
    J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?
    Gucer F; Misirlioglu S; Ceydeli N; Taskiran C
    J Robot Surg; 2018 Mar; 12(1):49-58. PubMed ID: 28255734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
    Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
    Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
    Horowitz NS; Dehdashti F; Herzog TJ; Rader JS; Powell MA; Gibb RK; Grigsby PW; Siegel BA; Mutch DG
    Gynecol Oncol; 2004 Dec; 95(3):546-51. PubMed ID: 15581961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
    Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
    Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.
    Yildirim Y; Sehirali S; Avci ME; Yilmaz C; Ertopcu K; Tinar S; Duman Y; Sayhan S
    Gynecol Oncol; 2008 Jan; 108(1):154-9. PubMed ID: 17945337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer.
    Sun SS; Chen TC; Yen RF; Shen YY; Changlai SP; Kao A
    Anticancer Res; 2001; 21(4B):2957-61. PubMed ID: 11712793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
    Tsai CS; Lai CH; Chang TC; Yen TC; Ng KK; Hsueh S; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):477-84. PubMed ID: 19464824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
    Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings.
    Ramirez PT; Jhingran A; Macapinlac HA; Euscher ED; Munsell MF; Coleman RL; Soliman PT; Schmeler KM; Frumovitz M; Ramondetta LM
    Cancer; 2011 May; 117(9):1928-34. PubMed ID: 21509770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False negative rate at
    Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
    BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcome of cervical carcinoma with locoregional lymph node involvement by FDG-PET].
    Paumier A; Blanchard P; Mazeron R; Dumas I; Morice P; Lhomme C; Leboulleux S; Haie-Meder C
    Cancer Radiother; 2012 May; 16(3):183-9. PubMed ID: 22387194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
    Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [
    Adam JA; van Diepen PR; Mom CH; Stoker J; van Eck-Smit BLF; Bipat S
    Gynecol Oncol; 2020 Nov; 159(2):588-596. PubMed ID: 32921477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
    Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutch DG; Powell MA; Grigsby PW
    J Clin Oncol; 2010 Apr; 28(12):2108-13. PubMed ID: 20308664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
    Tsai CS; Chang TC; Lai CH; Tsai CC; Ng KK; Hsueh S; Yen TC; Hong JH
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1506-12. PubMed ID: 15050330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
    Shim SH; Kim DY; Lee SJ; Kim SN; Kang SB; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jan; 144(1):40-45. PubMed ID: 27855989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.